X0206 3 2017-10-12 0 0001494650 OptiNose, Inc. OPTN 0001194459 DOYLE WILLIAM F C/O WFD VENTURES LLC 1500 BROADWAY, 17TH FLOOR NEW YORK NY 10036 1 0 1 0 Series B-2 Convertible Preferred Stock Common Stock 13177 D Series C-1 Convertible Preferred Stock Common Stock 3297 D Series C-2 Convertible Preferred Stock Common Stock 1365 D Series D Convertible Preferred Stock Common Stock 964 D Series B-2 Convertible Preferred Stock Common Stock 2077049 I By: TKWD Ventures LLC Series C Convertible Preferred Stock Common Stock 118865 I By: TKWD Ventures LLC Series C-1 Convertible Preferred Stock Common Stock 549971 I By: TKWD Ventures LLC Series C-2 Convertible Preferred Stock Common Stock 267254 I By: TKWD Ventures LLC Warrant (Right to Buy) 8.16 2020-11-01 Common Stock 10547 D Warrant (Right to Buy) 8.16 2020-11-01 Common Stock 1488366 I By: TKWD Ventures LLC On October 10, 2017, the Issuer effected a 2.8879-for-1 stock split of its issued and outstanding shares of common stock. All series of Convertible Preferred Stock will automatically convert into OptiNose, Inc. common stock on a 1-to-2.8879 basis upon the closing of the initial public offering into the number of shares of common stock shown in column 3 above and have no expiration date. The reportable securities are owned directly by TKWD Ventures LLC. Mr. Doyle is a managing director of WFD Ventures LLC, which is the general partner of TKWD Ventures LLC. Mr. Doyle possesses sole voting and investment power over shares owned by TKWD Ventures LLC. Mr. Doyle disclaims beneficial ownership in such securities, except to the extent of his pecuniary interest therein. All warrants are currently exercisable. Exercise price and number of warrant shares have been adjusted to reflect the Issuer's 2.8879-for-1 stock split of its issued and outstanding shares of common stock effected on October 10, 2017. Exhibit List: Exhibit 24 - Power of Attorney /s/ Leanne Kelly, attorney-in-fact 2017-10-12